Various Radiopharmaceuticals

The Department of the Army, specifically W40M MRC0 West, is soliciting quotes for the procurement of various radiopharmaceuticals to support Brooke Army Medical Center at JBSA Fort Sam Houston, Texas. This requirement, identified under solicitation number W81K0025QA125, is classified under NAICS code 325412 for Pharmaceutical Preparation Manufacturing and PSC 6505 for Drugs and Biologicals. The acquisition is unrestricted, as there is no set-aside designated for this effort.

The resulting contract will be a firm-fixed-price Indefinite Delivery Indefinite Quantity (IDIQ) agreement. While the description indicates an intended period of performance from October 1, 2025, through September 30, 2030, a recent amendment revised the requirement from a five-year ordering period to a one-year ordering period. The scope includes the delivery of radiopharmaceutical products, such as Ioflupane, and incorporates a post-award conference CLIN to satisfy the $100.00 minimum guarantee for the contract.

Responses for this solicitation are due by September 12, 2025, at 1600 CST. Performance will take place in San Antonio, Texas, and the primary point of contact for this requirement is Jaclyn Evans. The notice includes nine attachments, consisting of the Statement of Work and multiple solicitation amendments that address changes to clauses, ordering periods, and delivery specifications.